Additional file 4 of Genomic subtypes of non-muscle-invasive bladder cancer: guiding immunotherapy decision-making for patients exposed to aristolochic acid
This is a comprehensive genomic characterization of 40 urothelial bladder carcinoma (UBC) cell lines including information on origin, mutation status of genes implicated in bladder cancer (FGFR3, PIK3
Whole-organ histologic and genomic mapping (WOHGM) approach to analyze the molecular profile of bladder cancer evolution from mucosal field effects on a whole-organ scale Multiple samples from one bas
In this study, we aim to characterise the landscape of mutation and clonal selection in the human bladder. The data in this study will be generated by whole-genome sequencing of laser-dissected microb
Additional file 1: Readme. Index page for the constituent tables in this file. Table S1. Clinical phenotype for the 96 patients in the BCPP cohort. Table S2. Somatic mutations: Single Nucleotide varia
